Evidence map›Paper›PMID 26414751›Full record

ArticleAIDS research and human retroviruses2016

Plasma Cytokine Levels in Chronic Asymptomatic HIV-1 Subtype C Infection as an Indicator of Disease Progression in Botswana: A Retrospective Case Control Study.

Thato Iketleng, Sikhulile Moyo, Simani Gaseitsiwe, Balthazar Nyombi, Rebecca M Mitchell, Joseph Makhema, Marianna K Baum, Richard Marlink, Max Essex, Rosemary Musonda

Open access · greenAbstract read
In one paragraph

Article in AIDS research and human retroviruses, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Thato Iketleng1 Botswana-Harvard School of Public Health AIDS Initiative Partnership for HIV Research and Education (BHP) , Gaborone, Botswana .
Sikhulile Moyo1 Botswana-Harvard School of Public Health AIDS Initiative Partnership for HIV Research and Education (BHP) , Gaborone, Botswana .
Simani Gaseitsiwe1 Botswana-Harvard School of Public Health AIDS Initiative Partnership for HIV Research and Education (BHP) , Gaborone, Botswana .
Balthazar Nyombi2 Kilimanjaro Christian Medical University College , Moshi, Tanzania .
Rebecca M Mitchell4 Cornell University College of Veterinary Medicine , Ithaca, New York.
Joseph Makhema1 Botswana-Harvard School of Public Health AIDS Initiative Partnership for HIV Research and Education (BHP) , Gaborone, Botswana .
Marianna K Baum5 Florida International University, R. Stempel College of Public Health and Social Work, University Park , Miami, Florida.
Richard Marlink1 Botswana-Harvard School of Public Health AIDS Initiative Partnership for HIV Research and Education (BHP) , Gaborone, Botswana .
Max Essex1 Botswana-Harvard School of Public Health AIDS Initiative Partnership for HIV Research and Education (BHP) , Gaborone, Botswana .
Rosemary Musonda1 Botswana-Harvard School of Public Health AIDS Initiative Partnership for HIV Research and Education (BHP) , Gaborone, Botswana .
Botswana Harvard AIDS Institute Partnership · BWHarvard University · USCornell University · USKilimanjaro Christian Medical Centre · TZ

Funding

Training in HIV Genomics, Treatment, and Cure Research in BotswanaD43TW009610 · FIC · THE BOTSWANA HARVARD HEALTH PARTNERSHIP · PI SHAHIN LOCKMAN, Joseph Moeketsi Makhema · 2013 to 2026
$4.4M
FIC NIH HHS D43 TW009610
6 · The paper itself

Abstract

HIV infects cells of the immune system causing immune activation and proliferation of immune cells, leading to alteration of production and activity of a number of cytokines. These changes in cytokine levels can affect the immune function, and have the potential to directly impact the course of HIV disease. We characterized plasma cytokine concentration profiles in HIV-1 subtype C chronically infected, antiretroviral therapy (ART)-naive participants to establish their influence on disease progression and viremia. Plasma levels of interleukin (IL)-1α, IL-7, IL-12p40, granulocyte macrophage-colony-stimulating factor (GM-CSF), and interferon (IFN)-γ were quantified in samples from 60 treatment-naive participants in the placebo arm of the completed Micronutrient-HIV disease progressions study, "Dikotlana" (2004-2009) in Gaborone, Botswana. Participants were stratified into progressors (P) and nonprogressors (NP) based on their rates of CD4(+) T cell depletion during the study period. Nonprogressors were those who had <1% CD4(+) T cell depletion at 24 months postenrollment. Progressors were defined as those with CD4(+) T cell depletion of >15% at 24 months postenrollment. Cytokine levels were compared between P and NP using the Mann-Whitney U-test. Logistic regression analysis was used to determine if cytokines predicted disease progression. Correlations of cytokines with CD4(+) T cell counts and viral loads were determined by the Spearman rank test. Median baseline CD4(+) T cell counts were 453 (Q1, Q3; 401, 592) and 479 (Q1, Q3; 401-592) for nonprogressors and progressors, respectively. Nonprogressors had a higher viral set point than progressors. IL-12p40 levels were significantly higher in the P than in NP at enrollment and 24 months (p < 0.05). Levels of IL-1α, IL-7, IFN-γ, and GM-CSF did not differ significantly between the two groups. Except for IL-12p40, which displayed an inverse correlation with CD4(+) T cell counts and a direct correlation with viral load, all other cytokines showed no correlations. IL-12p40 was found to be the most significant predictor of progression and its production was most likely driven by HIV replication products as evidenced by its direct correlation with viral load. In chronic HIV-1 subtype C infection, CD4(+) T cell counts and plasma cytokine levels may not necessarily evolve in parallel, suggesting the involvement of other factors in determining the rates of CD4(+) T cell depletion.

Indexed as

Asymptomatic InfectionsAdultBotswanaCase-Control StudiesCD4 Lymphocyte CountCytokinesDisease ProgressionFemaleHIV-1HIV InfectionsHumansMaleMiddle AgedPlacebosPlasmaRetrospective StudiesCytokinesPlacebos

Identifiers

PMID26414751
PMCPMC5220552
OpenAlexW1778861586

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.